Strides Pharma Science Limited Market Cap ($1.03 Billion)
Market Cap & Net Worth: Strides Pharma Science Limited (STAR)
Strides Pharma Science Limited market cap. Strides Pharma Science Limited (NSE:STAR) has a market capitalization of $1.03 Billion (Rs95.61 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #8422 globally and #417 in its home market, demonstrating a 0.41% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Strides Pharma Science Limited's stock price Rs1037.30 by its total outstanding shares 92172714 (92.17 Million). Also see Strides Pharma Science Limited cash conversion from operations for how efficiently the company converts equity into cash flow.
Strides Pharma Science Limited Market Cap History (2015–2026)
Strides Pharma Science Limited market cap history from 2015 to 2026. Data shows change from $1.12 Billion to $1.03 Billion (-0.76% CAGR). Check Strides Pharma Science Limited stock price for real-time trading data and today's change.
Index Memberships
Strides Pharma Science Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$142.42 Billion | 0.73% | #46 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.10 Trillion | 0.03% | #345 of 750 |
Weight: Strides Pharma Science Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Strides Pharma Science Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Strides Pharma Science Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore STAR net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.02x
Strides Pharma Science Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.19x
Strides Pharma Science Limited's market cap is 0.19 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $722.36 Million | $27.55 Billion | $1.81 Billion | 0.03x | 0.40x |
| 2018 | $435.75 Million | $28.45 Billion | -$457.92 Million | 0.02x | N/A |
| 2019 | $356.06 Million | $21.20 Billion | $523.08 Million | 0.02x | 0.68x |
| 2020 | $868.06 Million | $26.83 Billion | $241.47 Million | 0.03x | 3.59x |
| 2021 | $443.30 Million | $32.80 Billion | $2.55 Billion | 0.01x | 0.17x |
| 2022 | $346.92 Million | $30.59 Billion | -$4.60 Billion | 0.01x | N/A |
| 2023 | $645.99 Million | $36.68 Billion | -$2.21 Billion | 0.02x | N/A |
| 2024 | $657.30 Million | $38.28 Billion | -$1.20 Billion | 0.02x | N/A |
| 2025 | $897.48 Million | $44.75 Billion | $4.05 Billion | 0.02x | 0.22x |
| 2026 | $1.03 Billion | $48.59 Billion | $5.56 Billion | 0.02x | 0.19x |
Competitor Companies of STAR by Market Capitalization
Companies near Strides Pharma Science Limited in the global market cap rankings as of November 4, 2026. Also see Strides Pharma Science Limited assets under control for a full breakdown of the balance sheet.
Key companies related to Strides Pharma Science Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Strides Pharma Science Limited (2015–2026)
Market capitalization of Strides Pharma Science Limited from 2015 to today. Between 2015 and today, Strides Pharma Science Limited's market cap moved from $1.12 Billion to $ 1.03 Billion, with a yearly change of -0.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.03 Billion | +15.21% |
| 2025 | Rs897.48 Million | +36.54% |
| 2024 | Rs657.30 Million | +1.75% |
| 2023 | Rs645.99 Million | +86.21% |
| 2022 | Rs346.92 Million | -21.74% |
| 2021 | Rs443.30 Million | -48.93% |
| 2020 | Rs868.06 Million | +143.80% |
| 2019 | Rs356.06 Million | -18.29% |
| 2018 | Rs435.75 Million | -39.68% |
| 2017 | Rs722.36 Million | -22.11% |
| 2016 | Rs927.46 Million | -17.32% |
| 2015 | Rs1.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Strides Pharma Science Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.03 Billion USD |
| MoneyControl | $1.03 Billion USD |
| MarketWatch | $1.03 Billion USD |
| marketcap.company | $1.03 Billion USD |
| Reuters | $1.03 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Strides Pharma Science Limited
Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasalsprays, topical formulations, an… Read more